These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 19693938

  • 21. Detection of BRAF mutations in thyroid nodules by allele-specific PCR using a dual priming oligonucleotide system.
    Lee HJ, Choi J, Hwang TS, Shong YK, Hong SJ, Gong G.
    Am J Clin Pathol; 2010 May; 133(5):802-8. PubMed ID: 20395530
    [Abstract] [Full Text] [Related]

  • 22. Molecular analysis of residual ThinPrep material from thyroid FNAs increases diagnostic sensitivity.
    Krane JF, Cibas ES, Alexander EK, Paschke R, Eszlinger M.
    Cancer Cytopathol; 2015 Jun; 123(6):356-61. PubMed ID: 25926393
    [Abstract] [Full Text] [Related]

  • 23. What to do with thyroid nodules showing benign cytology and BRAF(V600E) mutation? A study based on clinical and radiologic features using a highly sensitive analytic method.
    Kim SY, Kim EK, Kwak JY, Moon HJ, Yoon JH.
    Surgery; 2015 Feb; 157(2):354-61. PubMed ID: 25616949
    [Abstract] [Full Text] [Related]

  • 24. B-RAF V600E mutational analysis of fine needle aspirates correlates with diagnosis of thyroid nodules.
    Bentz BG, Miller BT, Holden JA, Rowe LR, Bentz JS.
    Otolaryngol Head Neck Surg; 2009 May; 140(5):709-14. PubMed ID: 19393416
    [Abstract] [Full Text] [Related]

  • 25. BRAFV600E mutation testing in fine needle aspirates of thyroid nodules: potential value of real-time PCR.
    Kwak JY, Han KH, Yoon JH, Kim EK, Moon HJ, Kim YL, Park SJ, Choi JR.
    Ann Clin Lab Sci; 2012 May; 42(3):258-65. PubMed ID: 22964613
    [Abstract] [Full Text] [Related]

  • 26. Value of BRAF V600E in High-Risk Thyroid Nodules with Benign Cytology Results.
    Chen X, Zhou Q, Wang F, Zhang F, Du H, Zhang Q, Wu W, Gong X.
    AJNR Am J Neuroradiol; 2018 Dec; 39(12):2360-2365. PubMed ID: 30498021
    [Abstract] [Full Text] [Related]

  • 27. Incidence and predictive factors of inadequate fine-needle aspirates for BRAF(V600E) mutation analysis in thyroid nodules.
    Lee KH, Kim HS, Han BK, Ko EY, Ki CS, Shin JH.
    AJR Am J Roentgenol; 2014 Feb; 202(2):391-6. PubMed ID: 24450682
    [Abstract] [Full Text] [Related]

  • 28. Evaluation of thyroid fine-needle aspirations: can ThinPrep be used exclusively to appropriately triage patients having a thyroid nodule?
    Duncan LD, Forrest L, Law WM, Hubbard E, Stewart LE.
    Diagn Cytopathol; 2011 May; 39(5):341-8. PubMed ID: 21488177
    [Abstract] [Full Text] [Related]

  • 29. [Expression of BRAF V600E mutation in different thyroid lesions].
    Wang W, Li XH, Zhang YH, Li J, Chen J, Zhao P, Li QY, Xiang JJ, Li X, Xu RJ.
    Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):354-7. PubMed ID: 21875464
    [Abstract] [Full Text] [Related]

  • 30. The mutational analysis in the diagnostic work-up of thyroid nodules: the real impact in a center with large experience in thyroid cytopathology.
    Macerola E, Rago T, Proietti A, Basolo F, Vitti P.
    J Endocrinol Invest; 2019 Feb; 42(2):157-166. PubMed ID: 29704233
    [Abstract] [Full Text] [Related]

  • 31. Pyrosequencing cut-off value identifying BRAFV600E mutation in fine needle aspiration samples of thyroid nodules.
    Yeo MK, Liang ZL, Oh T, Moon Y, An S, Kim MK, Kim KS, Shong M, Kim JM, Jo YS.
    Clin Endocrinol (Oxf); 2011 Oct; 75(4):555-60. PubMed ID: 21609347
    [Abstract] [Full Text] [Related]

  • 32. Combined analysis of galectin-3 and BRAFV600E improves the accuracy of fine-needle aspiration biopsy with cytological findings suspicious for papillary thyroid carcinoma.
    Sapio MR, Guerra A, Posca D, Limone PP, Deandrea M, Motta M, Troncone G, Caleo A, Vallefuoco P, Rossi G, Fenzi G, Vitale M.
    Endocr Relat Cancer; 2007 Dec; 14(4):1089-97. PubMed ID: 18045960
    [Abstract] [Full Text] [Related]

  • 33. Assessment of cellularity, genomic DNA yields, and technical platforms for BRAF mutational testing in thyroid fine-needle aspirate samples.
    Dyhdalo K, Macnamara S, Brainard J, Underwood D, Tubbs R, Yang B.
    Cancer Cytopathol; 2014 Feb; 122(2):114-22. PubMed ID: 24150898
    [Abstract] [Full Text] [Related]

  • 34. Detection of papillary thyroid carcinoma by analysis of BRAF and RET/PTC1 mutations in fine-needle aspiration biopsies of thyroid nodules.
    Musholt TJ, Fottner C, Weber MM, Eichhorn W, Pohlenz J, Musholt PB, Springer E, Schad A.
    World J Surg; 2010 Nov; 34(11):2595-603. PubMed ID: 20652698
    [Abstract] [Full Text] [Related]

  • 35. Comparison of the Clinical Validity of Droplet Digital PCR to ARMS-PCR for BRAF V600E Mutation Detection in Thyroid Nodules.
    Li X, Du H, Luo J, Ding W, Lai B, He J, Xu S, Zhang Y.
    J Clin Lab Anal; 2020 Nov; 34(11):e23458. PubMed ID: 32671901
    [Abstract] [Full Text] [Related]

  • 36. Contribution of the BRAF mutation analysis in calcified thyroid nodules.
    Yoo EY, Shin JH, Ko EY, Han BK.
    AJR Am J Roentgenol; 2012 Apr; 198(4):891-5. PubMed ID: 22451557
    [Abstract] [Full Text] [Related]

  • 37. Frequency assessment of BRAF mutation, KRas mutation, and RASSF1A methylation in nodular goitre based on fine-needle aspiration cytology specimens Ocena częstości występowania mutacji genów BRAF, KRas oraz.
    Koziołek M, Bińczak-Kuleta A, Stepaniuk M, Parczewski M, Andrysiak-Mamos E, Sieradzka A, Safranow K, Osowicz-Korolonek L, Kiedrowicz B, Kram A, Ciechanowicz A, Syrenicz A.
    Endokrynol Pol; 2015 Apr; 66(5):384-93. PubMed ID: 26457492
    [Abstract] [Full Text] [Related]

  • 38. Initial clinical experience with BRAF(V600E) mutation analysis of core-needle biopsy specimens from thyroid nodules.
    Choi SH, Baek JH, Lee JH, Choi YJ, Ha EJ, Song DE, Kim JK, Chung KW, Kim TY, Kim WB, Shong YK.
    Clin Endocrinol (Oxf); 2016 Apr; 84(4):607-13. PubMed ID: 26215382
    [Abstract] [Full Text] [Related]

  • 39. Impact of molecular screening for point mutations and rearrangements in routine air-dried fine-needle aspiration samples of thyroid nodules.
    Eszlinger M, Krogdahl A, Münz S, Rehfeld C, Precht Jensen EM, Ferraz C, Bösenberg E, Drieschner N, Scholz M, Hegedüs L, Paschke R.
    Thyroid; 2014 Feb; 24(2):305-13. PubMed ID: 23837487
    [Abstract] [Full Text] [Related]

  • 40. Reduction of false-negative papillary thyroid carcinomas by the routine analysis of BRAF(T1799A) mutation on fine-needle aspiration biopsy specimens: a prospective study of 814 thyroid FNAB patients.
    Cañadas-Garre M, Becerra-Massare P, López de la Torre-Casares M, Villar-del Moral J, Céspedes-Mas S, Vílchez-Joya R, Muros-de Fuentes T, García-Calvente C, Piédrola-Maroto G, López-Nevot MA, Montes-Ramírez R, Llamas-Elvira JM.
    Ann Surg; 2012 May; 255(5):986-92. PubMed ID: 22504197
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.